[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Biosimilar Drug Industry 2016

September 2016 | 164 pages | ID: C9376F833CCEN
QYResearch

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The China Biosimilar Drug Industry 2016 is a professional and in-depth study on the current state of the Biosimilar Drug industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The biosimilar drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (North China, East China, etc.), and other regions can be added.

Then, the report focuses on China major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the biosimilar drug industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 INDUSTRY OVERVIEW

1.1 Definition and Specifications of Biosimilar Drug
1.2 Classification of Biosimilar Drug
  1.2.1 Injection
  1.2.2 Tablets
  1.2.3 Others
1.3 Applications of Biosimilar Drug
  1.3.1 Ankylosing Spondylitis
  1.3.2 Tumor
  1.3.3 Rheumatoid Arthrtis
  1.3.4 Cardiovascular
1.4 Industry Chain Structure of Biosimilar Drug
1.5 Industry Policy Analysis of Biosimilar Drug
1.6 Industry News Analysis of Biosimilar Drug

2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIOSIMILAR DRUG

2.1 Bill of Materials (BOM) of Biosimilar Drug
2.2 Labor Cost Analysis of Biosimilar Drug
2.3 Depreciation Cost Analysis of Biosimilar Drug
2.4 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.5 Manufacturing Process Analysis of Biosimilar Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BIOSIMILAR DRUG

3.1 Capacity and Commercial Production Date of China Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of China Key Biosimilar Drug Manufacturers in 2015
3.3 Product, R&D Status and Technology Source of China Biosimilar Drug Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of China Biosimilar Drug Key Manufacturers in 2015

4 CAPACITY, PRODUCTION AND REVENUE ANALYSIS OF BIOSIMILAR DRUG BY REGIONS, TYPES AND MANUFACTURERS

4.1 China Capacity, Production and Revenue of Biosimilar Drug by Regions 2011-2016
4.2 China and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2011-2016
4.3 China Production and Revenue of Biosimilar Drug by Types 2011-2016
4.4 China Capacity, Production and Revenue of Biosimilar Drug by Manufacturers 2011-2016

5 PRICE, COST, GROSS AND GROSS MARGIN ANALYSIS OF BIOSIMILAR DRUG BY REGIONS, TYPES AND MANUFACTURERS

5.1 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Regions 2011-2016
5.2 Price and Gross Margin Analysis of Biosimilar Drug by Types 2011-2016
5.3 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Manufacturers 2011-2016

6 CONSUMPTION VOLUME, CONSUMPTION VALUE AND SALE PRICE ANALYSIS OF BIOSIMILAR DRUG BY REGIONS, TYPES AND APPLICATIONS

6.1 China Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2011-2016
6.2 China and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2011-2016
6.3 China Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2011-2016
6.4 Sale Price of Biosimilar Drug by Regions 2011-2016
6.5 Sale Price of Biosimilar Drug by Applications 2011-2016
6.6 Market Share Analysis of Biosimilar Drug by Different Sale Price Levels

7 SUPPLY, IMPORT, EXPORT AND CONSUMPTION ANALYSIS OF BIOSIMILAR DRUG

7.1 Supply, Consumption and Gap of Biosimilar Drug 2011-2016
7.2 China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016
7.3 North China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016
7.4 East China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016

8 ANALYSIS OF BIOSIMILAR DRUG INDUSTRY KEY MANUFACTURERS

8.1 CP Guojian
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
  8.1.4 Contact Information
8.2 Biotech
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
  8.2.4 Contact Information
8.3 Celgen
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
  8.3.4 Contact Information
8.4 Henlius Biotech
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
  8.4.4 Contact Information
8.5 Amgen
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Contact Information
8.6 Eli Lilly
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 Contact Information
8.7 Novartis
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Contact Information
8.8 Changchun High Tech
  8.8.1 Company Profile
  8.8.2 Contact Information
8.9 Innovent
  8.9.1 Company Profile
  8.9.2 Product Picture and Specification
  8.9.3 Contact Information

9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF BIOSIMILAR DRUG

9.1 Marketing Channels Status of Biosimilar Drug
9.2 Traders or Distributors of Biosimilar Drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilar Drug
9.4 China Import, Export and Trade Analysis of Biosimilar Drug

10 DEVELOPMENT TREND OF ANALYSIS OF BIOSIMILAR DRUG

10.1 Capacity, Production and Revenue Forecast of Biosimilar Drug by Regions and Types
  10.1.1 China Capacity, Production and Revenue of Biosimilar Drug by Regions 2016-2021
  10.1.2 China and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2016-2021
  10.1.3 China Capacity, Production and Revenue of Biosimilar Drug by Types 2016-2021
10.2 Consumption Volume and Consumption Value Forecast of Biosimilar Drug by Regions, Types and Applications
  10.2.1 China Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2016-2021
  10.2.2 China and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2016-2021
  10.2.3 China Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2016-2021
10.3 Supply, Import, Export and Consumption Forecast of Biosimilar Drug
  10.3.1 Supply, Consumption and Gap of Biosimilar Drug 2016-2021
  10.3.2 China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021
  10.3.3 North China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021
  10.3.4 East China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021

11 INDUSTRY CHAIN SUPPLIERS OF BIOSIMILAR DRUG WITH CONTACT INFORMATION

11.1 Major Raw Materials Suppliers of Biosimilar Drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information
11.3 Major Players of Biosimilar Drug with Contact Information
11.4 Key Consumers of Biosimilar Drug with Contact Information
11.5 Supply Chain Relationship Analysis of Biosimilar Drug

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF BIOSIMILAR DRUG

12.1 New Project SWOT Analysis of Biosimilar Drug
12.2 New Project Investment Feasibility Analysis of Biosimilar Drug

13 CONCLUSION OF THE CHINA BIOSIMILAR DRUG INDUSTRY 2016

TABLES AND FIGURES

Figure Picture of Biosimilar Drug
Table Product Specifications of Biosimilar Drug
Figure Industry Chain Structure of Biosimilar Drug
Table Industry Policy of Biosimilar Drug
Table Industry News List of Biosimilar Drug
Table Bill of Materials (BOM) of Biosimilar Drug
Figure APAC Overview of Average Monthly Labor Cost
Table Depreciation Cost of Biosimilar Drug
Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2015
Figure Manufacturing Process Analysis of Biosimilar Drug
Table Capacity (K DDD) and Commercial Production Date of China Biosimilar Drug Key Manufacturers in 2015
Table Manufacturing Plants Distribution of China Key Biosimilar Drug Manufacturers in 2015
Table Product of China Biosimilar Drug Key Manufacturers in 2015
Table R&D Status and Technology Source of China Biosimilar Drug Key Manufacturers in 2015
Table R&D Status of Chinese Biosimilar Drug by Other Key Players at the End of 2015
Table R&D Status of Chinese Biosimilar Drugs by Products in China at the End of 2015
Table Raw Materials Sources Analysis of China and China Biosimilar Drug Key Manufacturers in 2015
Table China Capacity (K DDD) of Biosimilar Drug by Regions 2011-2016
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2011
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2012
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2013
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2014
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2015
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2016
Table China Production (K DDD) of Biosimilar Drug by Regions 2011-2016
Figure China Production Market Share of Biosimilar Drug by Regions in 2011
Figure China Production Market Share of Biosimilar Drug by Regions in 2012
Figure China Production Market Share of Biosimilar Drug by Regions in 2013
Figure China Production Market Share of Biosimilar Drug by Regions in 2014
Figure China Production Market Share of Biosimilar Drug by Regions in 2015
Figure China Production Market Share of Biosimilar Drug by Regions in 2016
Table China Revenue (M $) of Biosimilar Drug by Regions 2011-2016
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2011
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2012
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2013
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2014
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2015
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2016
Figure China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016
Figure China Capacity Utilization Rate of Biosimilar Drug 2011-2016
Figure China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016
Figure North China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016
Figure North China Capacity Utilization Rate of Biosimilar Drug 2011-2016
Figure North China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016
Figure East China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016
Figure East China Capacity Utilization Rate of Biosimilar Drug 2011-2016
Figure East China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016
Table China Production (K DDD) of Biosimilar Drug by Types 2011-2016
Figure China Production Market Share of Biosimilar Drug by Types in 2011
Figure China Production Market Share of Biosimilar Drug by Types in 2012
Figure China Production Market Share of Biosimilar Drug by Types in 2013
Figure China Production Market Share of Biosimilar Drug by Types in 2014
Figure China Production Market Share of Biosimilar Drug by Types in 2015
Figure China Production Market Share of Biosimilar Drug by Types in 2016
Table China Revenue (M $) of Biosimilar Drug by Types 2011-2016
Figure China Revenue Market Share of Biosimilar Drug by Types in 2011
Figure China Revenue Market Share of Biosimilar Drug by Types in 2012
Figure China Revenue Market Share of Biosimilar Drug by Types in 2013
Figure China Revenue Market Share of Biosimilar Drug by Types in 2014
Figure China Revenue Market Share of Biosimilar Drug by Types in 2015
Figure China Revenue Market Share of Biosimilar Drug by Types in 2016
Table China Major Manufacturers Capacity (K DDD) of Biosimilar Drug 2011-2016
Table China Capacity Market Share of Biosimilar Drug Major Manufacturers 2011-2016
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2011
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2012
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2013
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2014
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2015
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2016
Table China Major Manufacturers Production (K DDD) of Biosimilar Drug 2011-2016
Table China Production Market Share of Biosimilar Drug Major Manufacturers 2011-2016
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2011
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2012
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2013
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2014
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2015
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2016
Table China Major Manufacturers Revenue (M $) of Biosimilar Drug 2011-2016
Table China Revenue Market Share of Biosimilar Drug Major Manufacturers 2011-2016
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2011
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2012
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2013
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2014
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2015
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2016
Table Price ($/DDD) of Biosimilar Drug by Regions 2011-2016
Figure Price ($/DDD) of Biosimilar Drug by Regions in 2015
Table Cost ($/DDD) of Biosimilar Drug by Regions 2011-2016
Figure Cost ($/DDD) of Biosimilar Drug by Regions in 2015
Table Gross ($/DDD) of Biosimilar Drug by Regions 2011-2016
Figure Gross ($/DDD) of Biosimilar Drug by Regions in 2015
Table Gross Margin of Biosimilar Drug by Regions 2011-2016
Figure Gross Margin of Biosimilar Drug by Regions in 2015
Table Price ($/DDD) of Biosimilar Drug by Types 2011-2016
Figure Price ($/DDD) of Biosimilar Drug by Types in 2015
Table Gross Margin of Biosimilar Drug by Types 2011-2016
Figure Gross Margin of Biosimilar Drug by Types in 2015
Table Price ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016
Figure Price ($/DDD) of Biosimilar Drug by Manufacturers in 2015
Table Cost ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016
Figure Cost ($/DDD) of Biosimilar Drug by Manufacturers in 2015
Table Gross ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016
Figure Gross ($/DDD) of Biosimilar Drug by Manufacturers in 2015
Table Gross Margin of Biosimilar Drug by Manufacturers 2011-2016
Figure Gross Margin ($/DDD) of Biosimilar Drug by Manufacturers in 2015
Table China Consumption Volume (K DDD) of Biosimilar Drug by Regions 2011-2016
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2011
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2012
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2013
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2014
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2015
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2016
Table China Consumption Value (M $) of Biosimilar Drug by Regions 2011-2016
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2011
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2012
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2013
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2014
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2015
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2016
Figure China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016
Figure China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016
Figure North China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016
Figure North China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016
Figure East China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016
Figure East China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016
Table China Consumption Volume (K DDD) of Biosimilar Drug by Applications 2011-2016
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2011
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2012
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2013
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2014
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2015
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2016
Table China Consumption Value (M $) of Biosimilar Drug by Applications 2011-2016
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2011
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2012
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2013
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2014
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2015
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2016
Table Sale Price ($/DDD) of Biosimilar Drug by Regions 2011-2016
Figure Sale Price ($/DDD) of Biosimilar Drug by Regions in 2015
Table Sale Price ($/DDD) of Biosimilar Drug by Applications 2011-2016
Figure Sale Price ($/DDD) of Biosimilar Drug by Application in 2015
Table Market Share of Biosimilar Drug by Different Sale Price Levels
Table China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD)
Table North China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD)
Table East China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD)
Table China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016
Table China Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K DDD)
Table North China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016
Table East China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016
Table CP Guojian Company Profile
Figure Biosimilar Drug Picture and Specifications of CP Guojian
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of CP Guojian 2011-2016E
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of CP Guojian 2011-2016E
Figure Biosimilar Drug Production (K DDD) and China Market Share of CP Guojian 2011-2016E
Table Biotech Company Profile
Table Biosimilar Drug Picture and Specifications of Biotech
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Biotech 2011-2016E
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Biotech 2011-2016E
Figure Biosimilar Drug Production (K DDD) and China Market Share of Biotech 2011-2016E
Table Celgen Company Profile
Figure Biosimilar Drug Picture and Specifications of Celgen
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Celgen 2011-2016E
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Celgen 2011-2016E
Figure Biosimilar Drug Production (K DDD) and China Market Share of Celgen 2011-2016E
Table Henlius Biotech Company Profile
Figure Biosimilar Drug Picture and Specifications of Henlius Biotech
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Henlius Biotech 2011-2016E
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Henlius Biotech 2011-2016E
Figure Biosimilar Drug Production (K DDD) and China Market Share of Henlius Biotech 2011-2016E
Table Amgen Company Profile
Figure Biosimilar Drug Picture and Specifications of Amgen
Table Eli Lilly Company Profile
Figure Biosimilar Drug Picture and Specifications of Eli Lilly
Table Novartis Company Profile
Figure Biosimilar Drug Picture and Specifications of Novartis
Table Changchun High Tech Company Profile
Table Innovent Company Profile
Figure Marketing Channels Status of Biosimilar Drug in 2015
Table Traders or Distributors of Biosimilar Drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Biosimilar Drug ($/DDD) in 2011-2016E
Table China Import, Export, and Trade of Biosimilar Drug (K DDD)
Table China Capacity (K DDD) of Biosimilar Drug by Regions 2016-2021
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2021
Table China Production (K DDD) of Biosimilar Drug by Regions 2016-2021
Figure China Production Market Share of Biosimilar Drug by Regions in 2021
Table China Revenue (M $) of Biosimilar Drug by Regions 2016-2021
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2021
Figure China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021
Figure China Capacity Utilization Rate of Biosimilar Drug 2016-2021
Figure China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021
Figure North China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021
Figure North China Capacity Utilization Rate of Biosimilar Drug 2016-2021
Figure North China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021
Figure East China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021
Figure East China Capacity Utilization Rate of Biosimilar Drug 2016-2021
Figure East China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021
Table China Production (K DDD) of Biosimilar Drug by Types 2016-2021
Figure China Production Market Share of Biosimilar Drug by Types in 2021
Table China Revenue (M $) of Biosimilar Drug by Types 2016-2021
Figure China Revenue Market Share of Biosimilar Drug by Types in 2021
Table China Consumption Volume (K DDD) of Biosimilar Drug by Regions 2016-2021
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2016
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2021
Table China Consumption Value (M $) of Biosimilar Drug by Regions 2016-2021
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2016
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2021
Figure China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021
Figure China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021
Figure North China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021
Figure North China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021
Figure East China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021
Figure East China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021
Table China Consumption Volume (K DDD) of Biosimilar Drug by Applications 2016-2021
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2021
Table China Consumption Value (M $) of Biosimilar Drug by Applications 2016-2021
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2021
Table China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD)
Table North China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD)
Table East China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD)
Table China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021
Table China Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K DDD)
Table North China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021
Table East China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021
Table Major Raw Materials Suppliers of Biosimilar Drug with Contact Information
Table Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information
Table Major Players of Biosimilar Drug with Contact Information
Table Key Consumers of Biosimilar Drug with Contact Information
Figure Supply Chain Relationship Analysis of Biosimilar Drug
Table New Project SWOT Analysis of Biosimilar Drug
Table New Project Investment Feasibility Analysis of Biosimilar Drug


More Publications